TC BioPharm (Holdings) PLC (TCBP)
1.14
+0.01
(+0.88%)
USD |
NASDAQ |
May 28, 16:00
1.14
0.00 (0.00%)
After-Hours: 06:07
TC BioPharm Cash and Short Term Investments (Quarterly): 1.238M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 1.238M |
June 30, 2023 | 2.420M |
December 31, 2022 | 5.819M |
June 30, 2022 | 7.274M |
Date | Value |
---|---|
December 31, 2021 | 2.114M |
September 30, 2021 | 2.082M |
December 31, 2020 | 1.019M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
1.019M
Minimum
Dec 2020
7.274M
Maximum
Jun 2022
3.138M
Average
2.114M
Median
Dec 2021
Cash and Short Term Investments (Quarterly) Benchmarks
Adaptimmune Therapeutics PLC | 143.65M |
Biodexa Pharmaceuticals Plc | 7.606M |
NuCana PLC | 16.25M |
Autolus Therapeutics PLC | 758.53M |
Mereo BioPharma Group PLC | 48.66M |